Diagnostic Tool For Estrogen Receptor Positive Breast Cancer Patient Stratification
This technology is a set of biomarkers to stratify estrogen receptor positive breast cancer patients to see if they should receive anti-estrogen therapy or not.
Background:
Breast cancer, the second most common cancer among American women, will effect of 330,000 new patients this year. The most commonly diagnosed breast tumors are estrogen receptor...
Published: 4/3/2023
|
Inventor(s): Ghassan Mouneimne, Marco Padilla-Rodriguez
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Healthcare Portfolios > Women's Health, Technology Classifications > Life Sciences > Diagnostics
|